Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030033021 A1
Publication typeApplication
Application numberUS 10/195,334
Publication dateFeb 13, 2003
Filing dateJul 15, 2002
Priority dateJul 16, 2001
Also published asEP1416886A2, EP1416886A4, EP1416887A2, EP1416887A4, US8012205, US20030033022, WO2003007787A2, WO2003007787A3, WO2003007879A2, WO2003007879A3
Publication number10195334, 195334, US 2003/0033021 A1, US 2003/033021 A1, US 20030033021 A1, US 20030033021A1, US 2003033021 A1, US 2003033021A1, US-A1-20030033021, US-A1-2003033021, US2003/0033021A1, US2003/033021A1, US20030033021 A1, US20030033021A1, US2003033021 A1, US2003033021A1
InventorsPamela Plouhar, Herbert Schwartz, Prasanna Malaviya
Original AssigneePlouhar Pamela Lynn, Schwartz Herbert Eugene, Prasanna Malaviya
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Cartilage repair and regeneration scaffold and method
US 20030033021 A1
Abstract
A method for the repair of a cartilaginous tissue defect, a cartilage repair device and a method of making a cartilage repair device are disclosed. In the method for the repair of a cartilaginous tissue defect, a device comprising a synthetic polymer is implanted into the defect, and a biological lubricant is administered to the defect. The device comprises a synthetic polymer and a biological lubricant.
Images(6)
Previous page
Next page
Claims(51)
1. A method for the repair of a cartilagenous tissue defect comprising the steps of
implanting a scaffold into the defect, and
administering a biological lubricant to the defect, wherein the biological lubricant is not crosslinked to the scaffold.
2. The method of claim 1, wherein the implanting step and administering step take place during a single surgical procedure.
3. The method of claim 2, further comprising an additional post-operative administration of biological lubricant to the defect.
4. The method of claim 1, wherein the biological lubricant comprises a GAG.
5. The method of claim 1, wherein the biological lubricant is selected from the group consisting of: hyaluronic acid; a salt of hyaluronic acid; sodium hyaluronate; dermatan sulfate; heparan sulfate; chondroiton sulfate; keratan sulfate; synovial fluid; a component of synovial fluid; vitronectin; and rooster comb hyaluronate.
6. The method of claim 1, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the biological lubricant is administered to the defect via injection in the area of the defect.
7. The method of claim 1, wherein the defect is in the knee and the biological lubricant is administered by injection into the knee joint cavity.
8. The method of claim 1, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
9. The method of claim 1, wherein the scaffold is provided pre saturated with biological lubricant
10. The method of claim 2, further comprising the step of
providing a series of additional biological lubricant injections to the area of the defect subsequent to the surgical procedure.
11. The method of claim 10, wherein the defect is in the knee joint and the injections are into the knee joint cavity.
12. The method of claim 10, wherein the series of additional biological lubricant injections comprises a first additional biological lubricant injection two weeks subsequent to the surgical procedure and a second additional biological lubricant injection four weeks subsequent to the surgical procedure.
13. The method of claim 1, wherein the defect is in a meniscus and implanting step is a surgical procedure comprising
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
14. The method of claim 1, wherein the scaffold comprises a synthetic polymer.
15. The method of claim 14, wherein the synthetic polymer has a structure selected from the group consisting of woven, knitted, warped knitted, nonwoven, braided, and foamed.
16. The method of claim 14, wherein the synthetic polymer is selected from the group consisting of PLA, PGA, PCL, PDO, TMC, PVA, copolymers thereof, and blends thereof.
17. The method of claim 14, wherein the scaffold further comprises an extracellular matrix.
18. The method of claim 1, wherein the device further comprises at least one additional substance selected from the group consisting of: a bioactive agent; a biologically derived substance; cells; and a biocompatible inorganic material.
19. A method for the repair of a cartilaginous tissue defect comprising the steps of
implanting a scaffold comprising a synthetic polymer into the defect, and
administering a GAG to the defect, wherein the GAG is not crosslinked to the scaffold.
20. The method of claim 19, wherein the GAG is not crosslinked to the scaffold.
21. The method of claim 20, wherein the implanting step and administering step take place during a single surgical procedure.
22. The method of claim 21, further comprising an additional post-operative administration of a biological lubricant to the defect.
23. The method of claim 22, wherein the biological lubricant of the additional post-operative administration comprises the GAG.
24. The method of claim 23, wherein the GAG comprises HA.
25. The method of claim 20, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the GAG is administered to the defect via injection in the area of the defect.
26. The method of claim 25, wherein the defect is in the knee and the injection is into the knee joint cavity.
27. The method of claim 20, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
28. The method of claim 20, wherein the scaffold is provided pre-saturated with biological lubricant.
29. The method of claim 19, further comprising a series of post-operative biological lubricant injections wherein the series of post-operative biological lubricant injections comprises a first post-operative lubricant injection two weeks subsequent to the surgical procedure and a second post-operative biological lubricant injection four weeks subsequent to the surgical procedure.
30. The method of claim 19, wherein the defect is in a meniscus and implanting step comprises
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
31. The method of claim 19, wherein the GAG is HA.
32. The method of claim 19, wherein the GAG is crosslinked to the scaffold.
33. The method of claim 19, wherein the scaffold consists essentially of the synthetic polymer.
34. A cartilage repair device comprising a synthetic polymer scaffold and a biological lubricant applied to the polymer.
35. The cartilage repair device of claim 34, wherein the biological lubricant comprises a solution.
36. The cartilage repair device of claim 34, wherein the biological lubricant solution comprises a GAG.
37. The cartilage repair device of claim 36, wherein the biological lubricant solution comprises HA.
38. The cartilage repair device of claim 37, wherein the HA is a high molecular weight sodium hyaluronate.
39. The cartilage repair device of claim 34, wherein the device further comprises a biologic component.
40. The cartilage repair device of claim 39, wherein the biologic component comprises an ECM.
41. The cartilage repair device of claim 40, wherein the ECM matrix comprises tissue derived from a source selected from the group consisting of: vertebrate small intestine submucosa; vertebrate liver basement membrane; vertebrate bladder submucosa; vertebrate stomach submucosa; vertebrate alimentary tissue; vertebrate respiratory tissue; and vertebrate genital tissue.
42. The cartilage repair device of claim 34, further comprising an additional material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
43. The cartilage repair device of claim 34 wherein the synthetic polymer scaffold comprises a plug configured to be positioned in an opening formed in damaged cartilage.
44. The cartilage repair device of claim 43 wherein the plug is secured to an anchor.
45. The cartilage repair device of claim 43 further comprising an anchor configured to secure the plug in the opening.
46. A method of making a cartilage repair device comprising:
providing a scaffold;
providing a biological lubricant in liquid form; and
wetting the scaffold with the liquid biological lubricant to form a wet implant.
47. The method of claim 46, further comprising packaging the wet implant and terminally sterilizing the packaged wet implant.
48. The method of claim 46, further comprising drying the wet implant, packaging the dry implant and terminally sterilizing the packaged dry implant.
49. The method of claim 46, wherein the scaffold comprises a synthetic polymer.
50. The method of claim 49, wherein the scaffold further comprises a naturally occurring extracellular matrix.
51. The method of claim 46, further comprising incorporating into the wet implant a material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
Description
  • [0001]
    This application claims priority to U.S. Provisional Application No. 60/388,724, filed Jun. 14, 2002, and U.S. Provisional Application No. 60/305,786, filed Jul. 16, 2001, hereby incorporated by reference.
  • CROSS REFERENCE
  • [0002]
    Cross reference is made to copending U.S. patent applications Ser. No. ______ entitled “Meniscus Regeneration Device and Method” (Attorney Docket No. 265280-71141, DEP-745); Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket No. 265280-71143, DEP-749); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751); Ser. No. ______ entitled “Cartilage Repair and Regeneration Device and Method” (Attorney Docket No. 265280-71145, DEP-752); Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747); and Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), each of which is assigned to the same assignee as the present application, each of which is filed concurrently herewith, and each of which is hereby incorporated by reference. Cross reference is also made to U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, which is assigned to the same assignee as the present application, and which is hereby incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Articular cartilage is a type of hyaline cartilage that lines the surfaces of the opposing bones in a diarthrodial joint (e.g. knee, hip, shoulder, etc.). Articular cartilage provides a near-frictionless articulation between the bones, while also functioning to absorb and transmit the compressive and shear forces encountered in the joint. Further, since the tissue associated with articular cartilage is aneural, these load absorbing and transmitting functions occur in a painless fashion in a healthy joint.
  • [0004]
    Fibrocartilage is found in diarthrodial joints, symphyseal joints, intervertebral discs, articular discs, as inclusions in certain tendons that wrap around a pulley, and at insertion sites of ligaments and tendons into bone. Made of a mixture of collagen type I and type II fibers, fibrocartilage can also be damaged, causing pain in the affected joint. It is understood for purposes of this application that the term “cartilage” includes articular cartilage and fibrocartilage.
  • [0005]
    When cartilage tissue is no longer healthy it can cause debilitating pain in the joint. For example, articular cartilage health can be affected by disease, aging, or trauma, all of which primarily involve a breakdown of the matrix consisting of a dense network of proteoglycan aggregates, collagen fibers, and other smaller matrix proteins. Tissue cells are unable to induce an adequate healing response because they are unable to migrate, being enclosed in lacunae surrounded by a dense matrix. Further, since the tissue is avascular, initiation of healing by circulating cells is limited. Similarly, damage or degeneration of knee fibrocartilage i.e. the menisci, is a common occurrence. A damaged or degenerated meniscus has little ability to heal or repair itself because the pathology frequently occurs in the avascular part of the tissue.
  • [0006]
    Several articular cartilage repair strategies have been attempted in the past. These include surgical techniques such as microfracturing or performing abrasion arthroplasty on the bone bed to gain vascular access, and hence, stimulate extrinsic repair in the defective region. The long-term outcome of these techniques, however, has been known to result in mechanically inferior fibrocartilagenous tissue.
  • [0007]
    Another surgical technique is mosaicplasty or osteochondral autograft transfer system (OATS). In this case, cylindrical plugs of healthy articular cartilage from a low-load bearing region of the knee are taken and transplanted into the defective region. This technique, however, can result in excessive donor-site morbidity and associated pain. Additionally, surgeons have reported that the gaps between the round transplants are frequently filled with fibrocartilage which can eventually erode away, thus potentially compromising the integrity of repair throughout the affected area.
  • [0008]
    The only FDA-approved cartilage treatment product in the market involves autologous chondrocyte implantation (CartiCel™). Autologous chondrocyte implantation involves performing an initial biopsy of healthy cartilage from the patient, isolating the cells from the tissue, expanding the cells in vitro by passaging them in culture, and then reintroducing the cells into the defective area. The cells are retained within the defect by applying a periosteal tissue patch over the defect, suturing the edges of the patch to the host tissue, and then sealing with fibrin glue. The efficacy of this expensive procedure, however, has recently been put into question by studies that have shown that only a few of the injected cells are retained within the defect and that they may not significantly contribute to the repair process. The healing observed is similar to that observed with microfracture or abrasion of the bone bed, suggesting that it is the preparation of the bone bed and not the introduction of the cells that facilitates the healing process.
  • [0009]
    Tissue engineering strategies for healing cartilage are being investigated by several academic and commercial teams and show some promise. One approach primarily involves using a biocompatible biologic or synthetic scaffold to deliver cells or stimulants to the defect site. The scaffold material can be a purified biologic polymer in the form of a porous scaffold or a gel (purified collagens, glycoproteins, proteoglycans, polysaccharides, or the like in various combinations) or porous scaffolds of synthetic biodegradable polymers (PLA, PGA, PDS, PCL, or the like, in various combinations). Several challenges remain with this approach, however. Some of these challenges include retention of the active stimulant at the defect site, inability to control the rate of release of the stimulant (resulting in tissue necrosis due to overdose), and cytotoxicity of the cells due to the degradation by-products of the synthetic polymers.
  • [0010]
    In another technique, various collagen scaffolds have been used to provide a scaffold for repair and regeneration of damaged cartilage tissue. U.S. Pat. No. 6,042,610 to ReGen Biologics, hereby incorporated by reference, discloses the use of a device to regenerate meniscal fibrocartilage. The disclosed device comprises a bioabsorbable material made at least in part from purified collagen and glycosaminoglycans (GAG). Purified collagen and glycosaminoglycans are co-lyophilized to create a foam and then cross-linked to form the device. The device can be used to provide augmentation for a damaged meniscus. Related U.S. Pat. Nos. 5,735,903, 5,479,033, 5,306,311, 5,007,934, and 4,880,429 also disclose a meniscal augmentation device for establishing a scaffold adapted for ingrowth of meniscal fibrochondrocyts.
  • [0011]
    It is also known to use naturally occurring extracellular matrices (ECMs) to provide a scaffold for tissue repair and regeneration. One such ECM is small intestine submucosa (SIS). SIS has been described as a natural biomaterial used to repair, support, and stabilize a wide variety of anatomical defects and traumatic injuries. See, for example, Cook® Online New Release provided by Cook Biotech at “www.cookgroup.com”. The SIS material is reported to be a naturally-occurring collagenous matrix derived from porcine small intestinal submucosa that models the qualities of its host when implanted in human soft tissues. Further, it is taught that the SIS material provides a natural matrix with a three-dimensional structure and biochemical composition that attracts host cells and supports tissue remodeling. SIS products, such as Oasis material and Surgisis material, are commercially available from Cook Biotech, Bloomington, Ind.
  • [0012]
    An SIS product referred to as RESTORE Orthobiologic Implant is available from DePuy Orthopaedics, Inc. in Warsaw, Ind. The DePuy product is described for use during rotator cuff surgery, and is provided as a resorbable framework that allows the rotator cuff tendon to regenerate itself. The RESTORE Implant is derived from porcine small intestine submucosa that has been cleaned, disinfected, and sterilized. Small intestine submucosa (SIS) has been described as a naturally-occurring ECM composed primarily of collagenous proteins. Other biological molecules, such as growth factors, glycosaminoglycans, etc., have also been identified in SIS. See Hodde et al., Tissue Eng. 2(3): 209-217 (1996); Voytik-Harbin et al., J. Cell Biochem., 67:478-491 (1997); McPherson and Badylak, Tissue Eng., 4(1): 75-83 (1998); Hodde et al., Endothelium, 8(1):11-24 (2001); Hodde and Hiles, Wounds, 13(5): 195-201 (2001); Hurst and Bonner, J. Biomater. Sci. Polym. Ed., 12(11) 1267-1279 (2001); Hodde et al., Biomaterial, 23(8): 1841-1848 (2002); and Hodde, Tissue Eng., 8(2): 295-308 (2002), all of which are incorporated by reference herein. During seven years of preclinical testing in animals, there were no incidences of infection transmission form the implant to the host, and the RESTORE Implant has not decreased the systemic activity of the immune system. See Allman et al., Transplant, 17(11): 1631-1640 (2001); Allman et al., Tissue Eng., 8(1): 53-62 (2002).
  • [0013]
    While small intestine submucosa is available, other sources of submucosa are known to be effective for tissue remodeling. These sources include, but are not limited to, stomach, bladder, alimentary, respiratory, or genital submucosa, or liver basement membrane. See, e.g., U.S. Pat. Nos. 6,171,344, 6,099,567, and 5,554,389, hereby incorporated by reference. Further, while SIS is most often porcine derived, it is known that these various submucosa materials may be derived from non-porcine sources, including bovine and ovine sources. Additionally, other collagenous matrices are known, for example lamina propria and stratum compactum.
  • [0014]
    It is also known to promote cartilage growth using glycosaminoglycans (GAG), such as hyaluronic acid (HA), dermatan sulfate, heparan sulfate, chondroiton sulfates, keratin sulfate, etc. See, e.g., U.S. Pat. Nos. 6,251,876 and 6,288,043, hereby incorporated by reference. GAGs are naturally found mostly in the extracellular matrix and on the cell surface as proteoglycans. These macromolecules are secreted by cells and play a role in both signal transduction and storage of some growth factors. In addition to the biological functions, the viscoelastic properties of GAGs provide a mechanical function by providing lubrication within a joint, to decrease friction. Hyaluronic acid is a natural component of the extracellular matrix of most cartilage tissues. HA is a linear polymer made up of repeating GAG disaccharide units of D-glucuronic acid and N-acetylglycosamine in β(1-3) and β(1-4) linkages. Illustratively HA can have a molecular weight ranging from about 300,000 kDa to about 6,000,000 kDa and can be uncrosslinked, naturally crosslinked, or crosslinked using mechanical, chemical, or enzymatic methods. The effect of treating extrasynovial tendons with HA and chemically modified HA has also been studied with reference to tendon gliding resistance and tendon adhesions to surrounding tissue after repair. Momose, Amadio, Sun, Chunfeng Zhao, Zobitz, Harrington and An, “Surface Modification of Extrasynovial Tendon by Chemically Modified Hyaluronic Acid Coating,” J. Biomed. Mater. Res. 59: 219-224 (2002).
  • SUMMARY OF THE INVENTION
  • [0015]
    It has been found that the combination of a biocompatible scaffold and HA produces a synergistic effect. Healing rates and/or quality of healing is better than the healing expected from additive effects of the scaffold or HA alone. Moreover, it has been found that retention of HA at the defect site is not problematic and co-administration of the scaffold and HA does not require HA to be cross-linked to the scaffold material. Thus, the present invention provides methods for the repair of damaged or diseased cartilaginous tissue, wherein a biocompatible scaffold and HA are co-administered to the cartilaginous tissue defect.
  • [0016]
    In addition to HA, GAGs such as dermatan sulfate, heparan sulfate, chondroitin sulfate, and keratan sulfate are also expected to be usable with the present invention. As used herein, “biological lubricant” is used to identify the aforementioned materials and others such as synovial fluid and components thereof, including mucinous glycoproteins (for example lubricin), tribonectins, articular cartilage superficial zone proteins, surface-active phospholipids, and lubricating glycoproteins I, II; vitronectin; and rooster comb hyaluronate (e.g. commercially available HEALON®, (Pharmacia Corporation, Peapack, N.J.), for example, and mixtures thereof. Such materials serve both a biological and a mechanical function: they play a biological role in directly and indirectly influencing cellular behavior by being involved in signal transduction alone or in conjunction with other extracellular matrix components such as growth factors, glycoproteins, collagens etc., and a mechanical role in providing lubrication. Thus, the use of the expression “biological lubricant” is intended to encompass materials that provide some biological function (influencing cellular behavior) and some mechanical function (lubrication).
  • [0017]
    It is believed that some commercially-available biological lubricants can be used in the practice of the present invention. Examples of such commercially-available lubricants include: ARTHREASE™ high molecular weight sodium hyaluronate, available in Europe from DePuy Orthopaedics, Inc. of Warsaw, Ind.; SYNVISC® Hylan G-F 20, manufactured by Biomatrix, Inc., of Ridgefield, N.J. and distributed by Wyeth-Ayerst Pharmaceuticals of Philadelphia, Pa.; and HYLAGAN® sodium hyaluronate, available from Sanofi-Synthelabo, Inc., of New York, N.Y. The expressions “HA”, “GAG”, and “biological lubricant” are intended to encompass these materials. It should be understood that there may be other salts of hyaluronic acid that may be used in the present invention, and the expressions “HA”, “GAG”, and “biological lubricant” should be understood to encompass such salts.
  • [0018]
    The three-dimensional biologic or synthetic scaffolds may be provided in the form of a fibrous nonwoven or foam material. The scaffold preferably has interconnecting pores or voids to facilitate the transport of nutrients and/or invasion of cells into the scaffold. The interconnected voids range in size, for example, from about 20 to 400 microns, illustratively 50 to 250 microns, depending on the application. The range of the void size in the construct can be manipulated by changing process steps during construct fabrication. See Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), already incorporated by reference. The foam optionally may be formed around a reinforcing material, for example, a knitted mesh or an ECM layer. See U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, already incorporated by reference. The fibers used to make the scaffold can be made of any biocompatible material, including bioabsorbable materials such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), copolymers or blends thereof, or combinations of synthetic and biologic polymers. See also, Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). The biologic polymers may comprise ECM, particularly comminuted ECM. In an exemplary embodiment, the fibers that comprise scaffold are formed of a polylactic acid and polyglycolic acid copolymer at a 95:5 mole ratio.
  • [0019]
    In one embodiment of the present invention, a method is provided wherein the scaffold material is implanted into the defect. The biological lubricant, which can be a GAG or HA for example, is administered separately, either at the time of surgery or via injection subsequent to closure of the incision. Optionally, a series of additional injections may be administered over a period of time. In either case, the injection may be made intra-articularly.
  • [0020]
    In another embodiment, a method is provided wherein the scaffold material and the biological lubricant are administered to the defect together. The scaffold material may be saturated with the biological lubricant at the time of surgery. Alternatively, the scaffold material may be saturated with the biological lubricant at the time of manufacture, and may be packaged together. Optionally, a series of additional injections may be administered in this method as well.
  • [0021]
    In still another embodiment, an implantable device is provided comprising a scaffold material saturated with a biological lubricant.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0022]
    [0022]FIG. 1 is a diagrammatical view showing a tibial platform with a typical meniscus structure on the platform and a portion of the meniscus removed for illustration purposes, the tibia platform being below the condyles of the femur;
  • [0023]
    [0023]FIG. 2 is a view looking down at the tibial platform and showing diagrammatically the insertion of a scaffold to replace the portion of the meniscus removed;
  • [0024]
    [0024]FIG. 3 shows the inserted scaffold in a position to be attached to the portions of the meniscus remaining after the injured portion is removed;
  • [0025]
    [0025]FIG. 4 is a sectional view taken from FIG. 3 along the lines 4-4;
  • [0026]
    [0026]FIG. 5 is a perspective view showing an open wedge-shaped device comprising an upper panel and a lower panel angularly separated to define an apex portion and a base portion;
  • [0027]
    [0027]FIG. 6 shows a wedge shaped device prior to folding with a pocket shown in imaginary lines formed in the device;
  • [0028]
    [0028]FIG. 7 shows a further step in the process in making the device shown in FIG. 6 to produce a filled, wedge-shaped device;
  • [0029]
    [0029]FIG. 8 is a top view of a ECM device used for the repair of a meniscal defect and having barbs for attachment;
  • [0030]
    [0030]FIG. 9 is a top view of a device similar to that shown in FIG. 1, except having sutures for attachment;
  • [0031]
    [0031]FIG. 10 is a perspective, partially cut-away view of a meniscus with the device of FIG. 1 inserted into the meniscus;
  • [0032]
    [0032]FIG. 11 is a cross sectional view of a cartilage repair device implanted in subchondral bone, note that the anchor is shown in elevation rather than cross section for clarity of description; and
  • [0033]
    [0033]FIG. 12 is a cross sectional view of a cartilage repair device which uses an alternative embodiment of an anchor.
  • DETAILED DESCRIPTION
  • [0034]
    While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
  • [0035]
    Referring to FIG. 1, it will be seen that a tibial platform 10 below the condyles 12 of a knee support a meniscus 11 from which an illustrative defective portion 14 is removed to leave a wedge-shaped space 16. In the removal process, the surgeon will often leave an outer rim 18 of the meniscus. The meniscus provides a large surface of articulation between the otherwise incongruent surfaces of the tibia platform or plateau and the femur condyles (such indicated at 12). The meniscus serves to reduce contact stresses and wear in the knee joint.
  • [0036]
    The portion 14 removed from the structure shown in FIG. 1 includes a portion of the original meniscus which was within the avascular zone, particularly the radially inner portion, and may include a portion of the original meniscus which was within the vascular zone.
  • [0037]
    [0037]FIG. 2 shows how a scaffold device 20 may illustratively be inserted into the space 16 to be against the outer rim 18. This illustrative scaffold 20 is shown in FIGS. 3 and 4 in position filling the space 16 and against the rim 18 left by the surgeon. FIG. 4 shows the scaffold as comprising an upper cover or upper panel 22 and a lower cover or lower panel 24. These panels 22, 24, which may illustratively be angularly related, will define an internal space 26 between the covers. Internal space 26 optionally may be filled with a biological material, a biological structure, or a synthetic structure providing a framework for regeneration of the meniscus into the space 16. Illustratively, panels 22, 24 may be made from woven or nonwoven mats of synthetic polymer or synthetic/biologic polymers. Alternatively, scaffold 20 may be constructed by forming the synthetic or synthetic/biologic polymers in a mold, or by sculpting a block of the polymer into the proper shape.
  • [0038]
    The scaffolds may comprise synthetic polymers such as polylactic acid (PLA), polyglocolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), and copolymers and blends thereof. The synthetic polymers may be provided as textiles with woven, knitted, warped knitted, nonwoven, braided, and foamed structures, and illustratively may be imbedded in ECM material, as in copending U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, or may be provided as foams with or without ECM materials, as in copending U.S. patent application Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). Thus, the scaffold may be made of biocompatible polymers, with or without a biologic component, and may be provided in a variety of woven, knitted, nonwoven, braided formed, or molded, or other configurations.
  • [0039]
    Scaffold 20 may be inserted, for example, in arthroscopic surgery through portals provided in the outer anterior surface of the knee opening into the knee cavity between the condyles 12 and the tibial platform 10. However, any surgical procedure to insert a device into damaged cartilage is within the scope of the present invention. Illustratively, the upper cover 22 of the scaffold 20 may serve as a bearing surface for the condyle 12 disposed thereabove and be subjected to the compression and stress forces involved in articulation of the knee. The condyle will move upon the upper surface of the cover 22.
  • [0040]
    Turning to FIGS. 5, 6 and 7, it will be seen that an illustrative device is somewhat diagrammatically illustrated. The illustrative device 30 includes an upper panel 32 and a lower panel 34 defining a wedge-shaped device having a base portion 36 and an apex portion 38. FIG. 6 suggests that the device may include a formed wedge-shaped cavity 39 (illustrated in phantom) and that the device may be folded about a fold line 40 to provide a device such as indicated at 42 in FIG. 7. While the FIG. 5 device 30 suggests an open wedge-shaped design, the device 42 in FIG. 7 suggests that, between the upper and lower panels 32, 34 a mass of biological material may be disposed. In FIG. 6, a plurality of tacks 44 are shown attached to one of the two panels of the device to be used for securing the device to surrounding tissue in the knee. The panels 32, 34 may be trimmed to the desired wedge shape.
  • [0041]
    Referring now to FIGS. 8-10, there are shown scaffolds similar to those shown in FIGS. 6-7, except that device 100 need not be wedge shaped. Scaffold 100 comprises panels 102 and 104, with a pillow 106 of biological or synthetic material shaped to fill the void in meniscus 111 left after a partial menisectomy, as illustrated in FIG. 1. The pillow is placed between panels 102 and 104. In the illustrative embodiment, pillow 106 is smaller than panels 102 and 104, and wing portions 105 of panels 102 and 104 extend beyond pillow 106.
  • [0042]
    As shown in FIG. 8, scaffold 100 may be provided with barbed darts 112 extending from wings 105. A needle or similar device would be used to push the barbed darts 112 into or through the meniscus to secure scaffold 100 to the meniscus. Barbed darts may be made of any biocompatible material sufficiently rigid to secure scaffold 100 to the meniscus. Barbed darts 112 may be provided integrally with scaffold 100 or may be added by the surgeon prior to insertion of the device.
  • [0043]
    The scaffold 100 illustrated in FIG. 9 is similar to the scaffold shown in FIG. 8, except that instead of barbed darts, the scaffold of FIG. 9 is provided with sutures 113. The scaffold of FIG. 9 may be affixed to the meniscus in a manner similar to that of the scaffold of FIG. 8. A needle or similar device would be used to push the sutures 113 through the meniscus. As illustrated in FIG. 10, the sutures may be tied together on the outside of the meniscus to form knots 120 that secure scaffold 100 in place.
  • [0044]
    While in the various embodiments discussed herein, tacks and sutures have been shown for anchoring the devices, it will be appreciated that the devices may be anchored by any other method at the choice of the surgeon.
  • [0045]
    [0045]FIGS. 11 and 12 illustrate several scaffolds that can be used in conjunction with a biological lubricant for cartilage repair. Referring now to FIG. 11, a cartilage repair device 210 is provided for repairing damaged or diseased cartilage. The device 210 includes an anchor 212 which is anchored or otherwise positioned in an opening formed in both a section of native cartilage 216 and the underlying subchondral bone 218. The anchor 212 is configured to be secured in an area from which damaged, diseased, or destroyed native cartilage and possibly bone have been removed. The anchor 212 includes an elongated central body portion 220 and a head portion 222. The body portion 220 extends downwardly from a lower surface of the head portion 222. As shown in FIG. 11, the body portion 220 may have a number of barbs 224 extending therefrom for engaging the sidewalls of the opening formed in the bone 218. In the illustrative embodiment described herein, the barbs 224 extend radially outwardly and are inclined slightly toward the head portion 222 of the anchor 212.
  • [0046]
    The cartilage repair device 210 also includes a plug 226. The plug 226 is secured to the anchor 212. Specifically, the plug 226 is secured to the upper surface of the head portion 222 of the anchor 212. The plug 226 allows for communication across the removed portion (i.e., the portion of the native cartilage 216 from which the damaged or diseased cartilage has been removed) and the adjacent healthy cartilage. As such, the plug 226 functions as a chondrogenic growth-supporting matrix for promoting a positive cellular response in an effort to achieve articular cartilage regeneration.
  • [0047]
    The anchor 212 of the cartilage repair device 210 may be constructed of numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer. Examples of such polymers include: polyesters of [alpha]-hydroxycarboxylic acids, such as poly(L-lactide) (PLLA), polyglycolide (PGA); poly-p-dioxanone (PDS); polycaprolactone (PCL); and any other bioresorbable and biocompatible polymer, co-polymer or mixture of polymers or co-polymers that are commonly used in the construction of prosthetic implants. Moreover, the anchor 212 may be constructed with a naturally occurring material such as a naturally occurring ECM (e.g., SIS). In such a case, the head portion 222 and body portion 220 of the anchor 212 may be configured as monolithic structures formed from naturally occurring ECM which is cured to be rigid and hardened to facilitate attachment to the bone 218. As such, it should be appreciated that the ECM material from which the anchor 212 is fabricated is cured to produce a structure which possesses the necessary hardness and toughness to allow the anchor 212 to be driven into bone tissue (i.e., the subchondral bone 218). See U.S. patent application Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748), already incorporated by reference. It should be understood that the material selected for the anchor 212 may also comprise mixtures or composites of materials. For example, the anchor 212 could comprise both a polymer and ECM material.
  • [0048]
    As mentioned above, the plug 226, which is fixed to the anchor 212, functions as a chondrogenic growth-supporting matrix for promoting vascular invasion and cellular proliferation in an effort to achieve articular cartilage regeneration. A central body 230 of the plug 226 is configured as a porous structure of biodegradable material. When anchored to a defective area of cartilage, cells can migrate into and proliferate within the plug 226, biodegrade the plug 226 while, at the same time, synthesize new and healthy tissue to heal the defective area. The plug 226 may be made out of a nonwoven or foam scaffold of synthetic or synthetic/biologic fibers with the desired porosity and material density. Specifically, the material density and/or porosity of the plug 226 may be varied to control cell migration and proliferation. The cells can migrate from adjacent tissue or from synovial fluid. The fibers from which the plug 226 is constructed also may be formed to have a structural rigidity sufficient to withstand the compression and shear stress to which the cartilage 216 is subjected. As such, the porous material from which the plug 226 is constructed should have the structural rigidity necessary to bear the forces associated with the other bone.
  • [0049]
    One particularly useful material for fabricating the plug 226 is a porous scaffold or “foam” composed of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM. Both the material density and the pore size of the foam plug 226 may be varied to fit the needs of a given plug design. Such foams may be fabricated by lyophilizing (i.e., freeze-drying) the fibers suspended in water. The material density and pore size of the resultant foam may be varied by controlling, among other things, the rate of freezing of the fiber suspension and/or the amount of water or moisture content in the fiber suspension at the on-set of the freezing process. See U.S. patent application Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket 265280-71143, DEP-7490 and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket 265280-71146, DEP-747), already incorporated by reference.
  • [0050]
    Referring now to FIG. 12, there is shown another embodiment of a cartilage repair device (hereinafter referred to with reference numeral 410). The cartilage repair device 410 is somewhat similar to the cartilage repair device 210. As such, the same reference numerals are used in FIG. 12 to identify components which have previously been discussed, with additional discussion thereof being unwarranted. The cartilage repair device 410 includes an anchor 412 which is used in lieu of the anchor 212 described in regard to FIG. 11. In particular, in the embodiment shown in FIG. 12, the plug 226 is positioned in an osteochondral defect 414 without the use of a bottom-mounted anchor (i.e., the anchor 212 of FIG. 11). Similarly to as described above, the plug 226 is constructed out of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM (e.g., SIS) having a desired porosity and material density.
  • [0051]
    The plug 226 is retained in the hole formed in the cartilage 216 and protected from in vivo forces by an annular shaped anchor 412. The anchor 412 may be provided in many different configurations which allow it to be press fit or otherwise anchored into the subchondral bone 218. For example, as shown in FIG. 12, the anchor 412 may be “bottle cap”-shaped so as to allow the anchor 412 to be press fit or otherwise secured into an annular groove 416 formed in the subchondral bone 218. The groove may be formed and the anchor may be shaped as described and shown in Patent Cooperation Treaty publication WO 01/39694 A2, published Jun. 7, 2001 entitled “Fixation Technology”, the complete disclosure of which is incorporated by reference herein. Alternatively, the anchor 412 may be mechanically secured to the subchondral bone 218 by use of adhesive or other types of anchoring structures (e.g., barbs).
  • [0052]
    The anchor 412 of the cartilage repair device 410 may be constructed from numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer such as PLLA, PGA, PDS, PCL, or any other such bioabsorbable polymer which is commonly used in the construction of prosthetic implants. Moreover, the anchor 412 may be constructed from a naturally occurring material such as a naturally occurring ECM (e.g., SIS) that is cured or otherwise fabricated to be rigid and hardened to facilitate attachment to the bone in the same manner as described above in regard to the anchor 212 and/or the plug 226 of FIG. 11.
  • [0053]
    It is expected that the teachings of the present invention may also be advantageously combined with the teachings of the following U.S. patent applications filed concurrently herewith and which are incorporated by reference herein: Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747). It is expected that the materials and devices disclosed in those patent applications can be used in the present invention.
  • [0054]
    Similarly, it is expected that other materials may be combined with the biological lubricant or with the scaffold. For example, bioactive agents, biologically-derived agents, cells, biocompatible inorganic material and/or combinations thereof may be mixed with the scaffold material or biological lubricant.
  • [0055]
    “Bioactive agents” include one or more of the following: chemotactic agents; therapeutic agents (e.g. antibiotics, steroidal and non-steroidal analgesics and anti-inflammatories, anti-rejection agents such as immunosuppressants and anti-cancer drugs); various proteins (e.g. short chain peptides, bone morphogenic proteins, glycoprotein and lipoprotein); cell attachment mediators; biologically active ligands; integrin binding sequence; ligands; various growth and/or differentiation agents (e.g. epidermal growth factor, IGF-I, IGF-II, TGF-β I-III, growth and differentiation factors, vascular endothelial growth factors, fibroblast growth factors, platelet derived growth factors, insulin derived growth factor and transforming growth factors, parathyroid hormone, parathyroid hormone related peptide, bFGF; TGFβ superfamily factors; BMP-2; BMP-4; BMP-6; BMP-12; sonic hedgehog; GDF5; GDF6; GDF8; PDGF); small molecules that affect the upregulation of specific growth factors; tenascin-C; hyaluronic acid; chondroitin sulfate; fibronectin; decorin; thromboelastin; thrombin-derived peptides; heparin-binding domains; heparin; heparan sulfate; DNA fragments; and DNA plasmids. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “bioactive agent” and “bioactive agents” unless expressly limited otherwise.
  • [0056]
    “Biologically derived agents” include one or more of the following: bone (autograft, allograft, and xenograft) and derivates of bone; cartilage (autograft, allograft, and xenograft), including, for example, meniscal tissue, and derivatives; ligament (autograft, allograft, and xenograft) and derivatives; derivatives of intestinal tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of stomach tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of bladder tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of alimentary tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of respiratory tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of genital tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of liver tissue (autograft, allograft, and xenograft), including for example liver basement membrane; derivatives of skin tissue; platelet rich plasma (PRP), platelet poor plasma, bone marrow aspirate, demineralized bone matrix, insulin derived growth factor, whole blood, fibrin and blood clot. Purified ECM and other collagen sources are also intended to be included within “biologically derived agents.” If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biologically-derived agent” and “biologically-derived agents” unless expressly limited otherwise.
  • [0057]
    “Biologically derived agents” also include bioremodelable collageneous tissue matrices. The expressions “bioremodelable collagenous tissue matrix” and “naturally occurring bioremodelable collageneous tissue matrix” include matrices derived from native tissue selected from the group consisting of skin, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, bladder, liver, stomach, fascia and intestine, tendon, whatever the source. Although “naturally occurring bioremodelable collageneous tissue matrix” is intended to refer to matrix material that has been cleaned, processed, sterilized, and optionally crosslinked, it is not within the definition of a naturally occurring bioremodelable collageneous tissue matrix to purify the natural fibers and reform a matrix material from purified natural fibers. The term “bioremodelable collageneous tissue matrices” includes “extracellular matrices” within its definition.
  • [0058]
    “Cells” include one or more of the following: chondrocytes; fibrochondrocytes; osteocytes; osteoblasts; osteoclasts; synoviocytes; bone marrow cells; mesenchymal cells; stromal cells; stem cells; embryonic stem cells; precursor cells derived from adipose tissue; peripheral blood progenitor cells; stem cells isolated from adult tissue; genetically transformed cells; a combination of chondrocytes and other cells; a combination of osteocytes and other cells; a combination of synoviocytes and other cells; a combination of bone marrow cells and other cells; a combination of mesenchymal cells and other cells; a combination of stromal cells and other cells; a combination of stem cells and other cells; a combination of embryonic stem cells and other cells; a combination of precursor cells isolated from adult tissue and other cells; a combination of peripheral blood progenitor cells and other cells; a combination of stem cells isolated from adult tissue and other cells; and a combination of genetically transformed cells and other cells. If other cells are found to have therapeutic value in the orthopaedic field, it is anticipated that at least some of these cells will have use in the present invention, and such cells should be included within the meaning of “cell” and “cells” unless expressly limited otherwise. Illustratively, in one example of embodiments that are to be seeded with living cells such as chondrocytes, a sterilized implant may be subsequently seeded with living cells and packaged in an appropriate medium for the cell type used. For example, a cell culture medium comprising Dulbecco's Modified Eagles Medium (DMEM) can be used with standard additives such as non-essential amino acids, glucose, ascorbic acid, sodium pyruvate, fungicides, antibiotics, etc., in concentrations deemed appropriate for cell type, shipping conditions, etc.
  • [0059]
    “Biocompatible inorganic materials” include materials such as hydroxyapatite, all calcium phosphates, alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate, polymorphs of calcium phosphate, sintered and non-sintered ceramic particles, and combinations of such materials. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biocompatible inorganic material” and “biocompatible inorganic materials” unless expressly limited otherwise.
  • [0060]
    It is expected that various combinations of bioactive agents, biologically derived agents, cells, biological lubricants, biocompatible inorganic materials, biocompatible polymers can be used with the scaffolds and methods of the present invention.
  • [0061]
    It is expected that standard disinfection and sterilization techniques may be used with the products of the present invention.
  • EXAMPLE 1
  • [0062]
    A defect in goat articular cartilage was repaired with a device as illustrated in FIG. 11. HA was applied post-operatively after repairing the defect with a synthetic scaffold according to FIG. 11. When compared to cartilage defects repaired without HA, the tissue repaired with both the device and HA appeared to be more mature, with a whiter, more hyaline-like appearance. Also, the repaired tissue that is treated with both the device and HA showed evidence of less severe degradative changes than is seen in the non-HA treated animals.
  • [0063]
    Although the examples all relate to use of HA, it is expected that other biological lubricants will provide similar benefits. It should be understood that the nature of the biological lubricant and the means of administering the biological lubricant can affect the quality of lubrication provided and can also affect the biological effects observed. For example, although a biological lubricant such as HA can be cross-linked to the matrix and still provide adequate lubrication, some GAG sulfates (e.g. chondroitin sulfate) can be expected to be less effective, or ineffective, as a lubricant if cross-linked or co-lyophilized with the underlying matrix, yet still be used for its biological effects. For some biological lubricants, it will be desirable to provide the biological lubricant in a fluidized form to maximize lubrication. In addition, different materials identified as falling within the definition of biological lubricants can be expected to have different efficacies as lubricants and different biological efficacies. Of the identified biological lubricants, those sharing properties (e.g. viscosity) similar to those of HA may provide greater clinical benefit as lubricants. Of the identified biological lubricants, those decreasing the coefficient of friction between the implant and healthy cartilage, compared to the case without the lubricant, are expected to be beneficial, and particularly those biological lubricants providing a reduced coefficient of friction for an extended period time. Other of the identified biological lubricants may provide greater clinical benefit as biologic agents. It should also be understood that materials identified as biological lubricants and the means of administering the material may be combined in various ways to take advantage of the properties of each and to maximize the clinical benefits of administering the various materials. Although the invention has been described in detail with reference to certain preferred embodiments, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3272204 *Sep 22, 1965Sep 13, 1966Ethicon IncAbsorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4105034 *Jun 10, 1977Aug 8, 1978Ethicon, Inc.Poly(alkylene oxalate) absorbable coating for sutures
US4140678 *Jun 13, 1977Feb 20, 1979Ethicon, Inc.Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4141087 *Jan 19, 1977Feb 27, 1979Ethicon, Inc.Isomorphic copolyoxalates and sutures thereof
US4205399 *May 26, 1978Jun 3, 1980Ethicon, Inc.Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4206511 *May 17, 1978Jun 3, 1980Mannesmann AktiengesellschaftLocating a welding seam
US4610397 *Oct 27, 1983Sep 9, 1986Urschel Laboratories IncorporatedComminuting equipment
US4669473 *Sep 6, 1985Jun 2, 1987Acufex Microsurgical, Inc.Surgical fastener
US4736372 *Sep 10, 1986Apr 5, 1988Siemens AktiengesellschaftMethod and apparatus of transmission for a digital signal
US4741330 *Apr 4, 1986May 3, 1988Hayhurst John OMethod and apparatus for anchoring and manipulating cartilage
US4750492 *Feb 27, 1985Jun 14, 1988Richards Medical CompanyAbsorbable suture apparatus, method and installer
US4846835 *Jun 15, 1987Jul 11, 1989Grande Daniel ATechnique for healing lesions in cartilage
US4956179 *Jul 2, 1987Sep 11, 1990Astra Lakemedel AktiebolagAntibacterial combination of penicillin and cephalosporin
US5102421 *Jun 14, 1990Apr 7, 1992Wm. E. Anpach, IIISuture anchor and method of forming
US5350583 *Nov 3, 1992Sep 27, 1994Terumo Kabushiki KaishaCell-penetrable medical material and artificial skin
US5447940 *Jul 27, 1994Sep 5, 1995Johnson & Johnson Medical, Inc.Absorbable composite materials for use in the treatment of periodontal disease
US5514181 *Sep 29, 1994May 7, 1996Johnson & Johnson Medical, Inc.Absorbable structures for ligament and tendon repair
US5520691 *Dec 13, 1994May 28, 1996Branch; Thomas P.Method and apparatus for re-approximating tissue
US5545178 *Oct 21, 1994Aug 13, 1996Kensey Nash CorporationSystem for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5595621 *Jun 7, 1995Jan 21, 1997Johnson & Johnson Medical, Inc.Method of making absorbable structures for ligament and tendon repair
US5595751 *Feb 8, 1996Jan 21, 1997Ethicon, Inc.Absorbable polyoxaesters containing amines and/or amido groups
US5597579 *Mar 5, 1996Jan 28, 1997Ethicon, Inc.Blends of absorbable polyoxaamides
US5607687 *Mar 5, 1996Mar 4, 1997Ethicon, Inc.Polymer blends containing absorbable polyoxaesters
US5618552 *Mar 5, 1996Apr 8, 1997Ethicon, Inc.Absorbable polyoxaesters
US5620698 *Jun 14, 1996Apr 15, 1997Ethicon, Inc.Blends of absorbable polyoxaesters containing amines and/or amido groups
US5626614 *Dec 22, 1995May 6, 1997Applied Medical Resources CorporationT-anchor suturing device and method for using same
US5630824 *Jun 1, 1994May 20, 1997Innovasive Devices, Inc.Suture attachment device
US5645850 *Aug 7, 1996Jul 8, 1997Ethicon, Inc.Blending containing absorbable polyoxaamides
US5648088 *Mar 5, 1996Jul 15, 1997Ethicon, Inc.Blends of absorbable polyoxaesters containing amines and/or amide groups
US5660225 *Nov 13, 1995Aug 26, 1997Saffran; Bruce NathanMethod of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues
US5725556 *Dec 15, 1995Mar 10, 1998M & R Medical, Inc.Suture locking apparatus
US5735897 *Jan 2, 1997Apr 7, 1998Scimed Life Systems, Inc.Intravascular stent pump
US5736372 *Apr 16, 1990Apr 7, 1998Massachusetts Institute Of TechnologyBiodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5759208 *Feb 29, 1996Jun 2, 1998The Procter & Gamble CompanyLaundry detergent compositions containing silicone emulsions
US5773577 *Mar 2, 1995Jun 30, 1998Protein Polymer TechnologiesProducts comprising substrates capable of enzymatic cross-linking
US5855610 *May 19, 1995Jan 5, 1999Children's Medical Center CorporationEngineering of strong, pliable tissues
US5859150 *Nov 5, 1997Jan 12, 1999Ethicon, Inc.Prepolymers of absorbable polyoxaesters
US5861004 *Aug 29, 1997Jan 19, 1999Kensey Nash CorporationHemostatic puncture closure system including closure locking means and method of use
US5863551 *Oct 16, 1996Jan 26, 1999Organogel Canada LteeImplantable polymer hydrogel for therapeutic uses
US5866165 *Jan 15, 1997Feb 2, 1999Orquest, Inc.Collagen-polysaccharide matrix for bone and cartilage repair
US5891558 *Nov 21, 1996Apr 6, 1999Tissue Engineering, Inc.Biopolymer foams for use in tissue repair and reconstruction
US5893888 *Sep 6, 1994Apr 13, 1999Tissue Engineering, Inc.Method and construct for producing graft tissue from extracellular matrix
US5899939 *Jan 21, 1998May 4, 1999Osteotech, Inc.Bone-derived implant for load-supporting applications
US5906997 *Jun 17, 1997May 25, 1999Fzio Med, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US5939323 *May 28, 1997Aug 17, 1999Brown UniversityHyaluronan based biodegradable scaffolds for tissue repair
US6010525 *Aug 1, 1997Jan 4, 2000Peter M. BonuttiMethod and apparatus for securing a suture
US6017301 *Feb 13, 1998Jan 25, 2000Fziomed, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6034140 *Feb 13, 1998Mar 7, 2000Fziomed, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6066160 *Nov 23, 1998May 23, 2000Quickie LlcPassive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6077989 *May 15, 1997Jun 20, 2000Kandel; RitaResorbable implant biomaterial made of condensed calcium phosphate particles
US6110212 *Feb 7, 1997Aug 29, 2000Kenton W. GregoryElastin and elastin-based materials
US6197296 *Mar 29, 1994Mar 6, 2001National Heart Research FundTissue equivalents
US6214048 *May 30, 1995Apr 10, 2001Matsumoto Dental CollegeBone substitute product and method of producing the same
US6242247 *Jun 2, 1997Jun 5, 2001Sulzer Orthopedics Ltd.Method for making cartilage and implants
US6258124 *May 10, 1999Jul 10, 2001C. R. Bard, Inc.Prosthetic repair fabric
US6264702 *Jul 22, 1998Jul 24, 2001Sofradim ProductionComposite prosthesis for preventing post-surgical adhesions
US6265333 *Dec 1, 1998Jul 24, 2001Board Of Regents, University Of Nebraska-LincolnDelamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
US6267957 *Jan 20, 1999Jul 31, 2001Howard GreenAttaching agents to tissue with transglutaminase and a transglutaminase substrate
US6270530 *Jun 9, 2000Aug 7, 2001C.R. Bard, Inc.Prosthetic repair fabric
US6280473 *Feb 23, 1999Aug 28, 2001Macropore, Inc.Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6280474 *Jul 27, 1999Aug 28, 2001Neucoll, Inc.Devices for tissue repair and methods for preparation and use thereof
US6358284 *Jun 2, 1999Mar 19, 2002Med Institute, Inc.Tubular grafts from purified submucosa
US6373221 *Dec 27, 2000Apr 16, 2002Kabushiki Kaisha Toyoda Jidoshokki SeisakushoCharger coupling
US6387693 *Apr 18, 2001May 14, 2002Sulzer Orthopedics Ltd.Method for producing cartilage tissue and implants for repairing enchondral and osteochondral defects as well as arrangement for carrying out the method
US6402766 *Feb 26, 2001Jun 11, 2002Ethicon, Inc.Graft fixation device combination
US6423073 *Feb 26, 2001Jul 23, 2002Ethicon, Inc.Instrument for inserting graft fixation device
US6436110 *Feb 26, 2001Aug 20, 2002Ethicon, Inc.Method of securing a graft using a graft fixation device
US6440444 *Jul 24, 2001Aug 27, 2002Osteotech, Inc.Load bearing osteoimplant and method of repairing bone using the same
US6508821 *Jan 28, 2000Jan 21, 2003Depuy Orthopaedics, Inc.Soft tissue repair material fixation apparatus and method
US6517564 *Feb 2, 2000Feb 11, 2003Arthrex, Inc.Bioabsorbable tissue tack with oval-shaped head and method of tissue fixation using same
US6566345 *Apr 26, 2001May 20, 2003Fziomed, Inc.Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6572650 *Jun 4, 1999Jun 3, 2003Organogenesis Inc.Bioengineered vascular graft support prostheses
US6592623 *Aug 31, 1999Jul 15, 2003Virginia Commonwealth University Intellectual Property FoundationEngineered muscle
US6692499 *Jul 2, 1997Feb 17, 2004Linvatec Biomaterials OySurgical fastener for tissue treatment
US6840962 *Sep 25, 2000Jan 11, 2005Massachusetts Institute Of TechnologyTissue engineered tendons and ligaments
US6869938 *Dec 27, 1999Mar 22, 2005Fziomed, Inc.Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6989034 *May 31, 2002Jan 24, 2006Ethicon, Inc.Attachment of absorbable tissue scaffolds to fixation devices
US20010002446 *Jan 23, 2001May 31, 2001Plouhar Pamela L.Tissue graft construct for replacement of cartilaginous structures
US20020031551 *Aug 6, 2001Mar 14, 2002Peterson Dale R.Bioerodable polymeric adhesives for tissue repair
US20020034533 *Sep 19, 2001Mar 21, 2002Peterson Dale R.Bioerodable polymeric adhesives for tissue repair
US20020038151 *Jul 30, 2001Mar 28, 2002Plouhar Pamela L.Reinforced small intestinal submucosa (SIS)
US20020052628 *May 24, 2001May 2, 2002Bowman Steven M.Graft fixation device and method
US20020095157 *Jan 24, 2002Jul 18, 2002Bowman Steven M.Graft fixation device combination
US20030014126 *Jun 28, 2002Jan 16, 2003Patel Umesh H.Graft prosthesis devices containing renal capsule collagen
US20030021827 *Jul 15, 2002Jan 30, 2003Prasanna MalaviyaHybrid biologic/synthetic porous extracellular matrix scaffolds
US20030023316 *Jun 14, 2002Jan 30, 2003Brown Laura JeanHybrid biologic-synthetic bioabsorable scaffolds
US20030032961 *Jul 15, 2002Feb 13, 2003Pelo Mark JosephDevices from naturally occurring biologically derived materials
US20030033022 *Jul 15, 2002Feb 13, 2003Plouhar Pamela LynnCartilage repair and regeneration device and method
US20030036797 *Jul 15, 2002Feb 20, 2003Prasanna MalaviyaMeniscus regeneration device and method
US20030036801 *Jul 15, 2002Feb 20, 2003Schwartz Herbert E.Cartilage repair apparatus and method
US20030044444 *Jul 15, 2002Mar 6, 2003Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20030049299 *Jul 15, 2002Mar 13, 2003Prasanna MalaviyaPorous delivery scaffold and method
US20030078617 *Jul 15, 2002Apr 24, 2003Schwartz Herbert E.Unitary surgical device and method
US20040059431 *Sep 5, 2003Mar 25, 2004Plouhar Pamela L.Reinforced small intestinal submucosa
US20040143344 *Dec 29, 2003Jul 22, 2004Prasanna MalaviyaImplantable tissue repair device and method
US20040166169 *Jul 15, 2002Aug 26, 2004Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20050027307 *Jul 15, 2002Feb 3, 2005Schwartz Herbert EugeneUnitary surgical device and method
USRE34021 *Nov 13, 1989Aug 4, 1992Abbott LaboratoriesPercutaneous fixation of hollow organs
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7531190May 25, 2005May 12, 2009Biomet Manufacturing Corp.Porous ceramic structure containing biologics
US7601176Oct 12, 2004Oct 13, 2009Tecres S.P.A.Disposable articulated spacing device for surgical treatment of joints of the human body
US7658751Sep 29, 2006Feb 9, 2010Biomet Sports Medicine, LlcMethod for implanting soft tissue
US7666230Dec 8, 2003Feb 23, 2010Depuy Products, Inc.Implant device for cartilage regeneration in load bearing articulation regions
US7749250Feb 3, 2006Jul 6, 2010Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US7780860May 19, 2008Aug 24, 2010Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US7785332Oct 28, 2005Aug 31, 2010Depuy Products, Inc.Method of delivering therapeutic implant
US7799089Oct 10, 2006Sep 21, 2010Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US7806276Apr 11, 2008Oct 5, 2010Hanuman, LlcBuoy suspension fractionation system
US7815926Jul 7, 2006Oct 19, 2010Musculoskeletal Transplant FoundationImplant for articular cartilage repair
US7819918 *Dec 29, 2003Oct 26, 2010Depuy Products, Inc.Implantable tissue repair device
US7820638 *Aug 7, 2003Oct 26, 2010Arthrex, Inc.Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US7824701Feb 25, 2003Nov 2, 2010Ethicon, Inc.Biocompatible scaffold for ligament or tendon repair
US7832566May 25, 2006Nov 16, 2010Biomet Biologics, LlcMethod and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7837740Jan 24, 2007Nov 23, 2010Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US7837884Dec 29, 2008Nov 23, 2010Hanuman, LlcMethods and apparatus for isolating platelets from blood
US7845499May 25, 2006Dec 7, 2010Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US7857830Oct 9, 2007Dec 28, 2010Biomet Sports Medicine, LlcSoft tissue repair and conduit device
US7857851Oct 28, 2005Dec 28, 2010Depuy Products, Inc.Implant system with sizing templates
US7871440Dec 11, 2006Jan 18, 2011Depuy Products, Inc.Unitary surgical device and method
US7875296Nov 29, 2007Jan 25, 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US7901457May 16, 2003Mar 8, 2011Musculoskeletal Transplant FoundationCartilage allograft plug
US7901461Dec 5, 2003Mar 8, 2011Ethicon, Inc.Viable tissue repair implants and methods of use
US7905903Nov 6, 2007Mar 15, 2011Biomet Sports Medicine, LlcMethod for tissue fixation
US7905904Jan 15, 2008Mar 15, 2011Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US7909851Jan 15, 2008Mar 22, 2011Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US7914539Dec 5, 2005Mar 29, 2011Biomet Sports Medicine, LlcTissue fixation device
US7914689May 19, 2008Mar 29, 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US7914808Jul 15, 2002Mar 29, 2011Depuy Products, Inc.Hybrid biologic/synthetic porous extracellular matrix scaffolds
US7959650Aug 22, 2008Jun 14, 2011Biomet Sports Medicine, LlcAdjustable knotless loops
US7992725Apr 11, 2008Aug 9, 2011Biomet Biologics, LlcBuoy suspension fractionation system
US8012205 *Jul 15, 2002Sep 6, 2011Depuy Products, Inc.Cartilage repair and regeneration device
US8016867Oct 28, 2004Sep 13, 2011Depuy Mitek, Inc.Graft fixation device and method
US8025896Jul 15, 2002Sep 27, 2011Depuy Products, Inc.Porous extracellular matrix scaffold and method
US8034090Mar 21, 2006Oct 11, 2011Biomet Sports Medicine, LlcTissue fixation device
US8048321Aug 11, 2010Nov 1, 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8062534Dec 6, 2010Nov 22, 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8088130May 29, 2009Jan 3, 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US8092529Jul 15, 2002Jan 10, 2012Depuy Products, Inc.Meniscus regeneration device
US8118836Aug 22, 2008Feb 21, 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US8119013Oct 4, 2010Feb 21, 2012Hanuman, LlcMethod of separating a selected component from a multiple component material
US8128640Aug 9, 2006Mar 6, 2012Ivy Sports Medicine LLCSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US8128658Aug 22, 2008Mar 6, 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US8137354Apr 25, 2007Mar 20, 2012Biomet Sports Medicine, LlcLocalized cartilage defect therapy
US8137382Aug 22, 2008Mar 20, 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US8137686Apr 20, 2004Mar 20, 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US8137702Dec 29, 2010Mar 20, 2012Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US8163184Mar 25, 2011Apr 24, 2012Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8187477Nov 22, 2010May 29, 2012Hanuman, LlcMethods and apparatus for isolating platelets from blood
US8221454Oct 27, 2009Jul 17, 2012Biomet Sports Medicine, LlcApparatus for performing meniscus repair
US8221500Jul 24, 2008Jul 17, 2012Musculoskeletal Transplant FoundationCartilage allograft plug
US8221780Jun 29, 2006Jul 17, 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US8226715Jun 30, 2003Jul 24, 2012Depuy Mitek, Inc.Scaffold for connective tissue repair
US8231654May 6, 2011Jul 31, 2012Biomet Sports Medicine, LlcAdjustable knotless loops
US8251998Feb 12, 2008Aug 28, 2012Biomet Sports Medicine, LlcChondral defect repair
US8273106Dec 22, 2010Sep 25, 2012Biomet Sports Medicine, LlcSoft tissue repair and conduit device
US8292921Mar 11, 2011Oct 23, 2012Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US8292968Feb 1, 2011Oct 23, 2012Musculoskeletal Transplant FoundationCancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8298262Jun 22, 2009Oct 30, 2012Biomet Sports Medicine, LlcMethod for tissue fixation
US8303604Sep 30, 2009Nov 6, 2012Biomet Sports Medicine, LlcSoft tissue repair device and method
US8313954Apr 3, 2009Nov 20, 2012Biomet Biologics, LlcAll-in-one means of separating blood components
US8317825Apr 7, 2009Nov 27, 2012Biomet Sports Medicine, LlcSoft tissue conduit device and method
US8328024Aug 4, 2011Dec 11, 2012Hanuman, LlcBuoy suspension fractionation system
US8337525Mar 11, 2011Dec 25, 2012Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US8337537Jul 15, 2002Dec 25, 2012Depuy Products, Inc.Device from naturally occurring biologically derived materials
US8337711Feb 27, 2009Dec 25, 2012Biomet Biologics, LlcSystem and process for separating a material
US8343227May 27, 2010Jan 1, 2013Biomet Manufacturing Corp.Knee prosthesis assembly with ligament link
US8361113Jun 22, 2009Jan 29, 2013Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US8366787Jun 14, 2002Feb 5, 2013Depuy Products, Inc.Hybrid biologic-synthetic bioabsorbable scaffolds
US8409253Jul 1, 2010Apr 2, 2013Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US8435551Jul 24, 2009May 7, 2013Musculoskeletal Transplant FoundationCancellous construct with support ring for repair of osteochondral defects
US8449561Feb 15, 2007May 28, 2013Depuy Mitek, LlcGraft fixation device combination
US8496970Feb 27, 2012Jul 30, 2013Depuy Mitek, LlcConformable tissue repair implant capable of injection delivery
US8500818May 27, 2010Aug 6, 2013Biomet Manufacturing, LlcKnee prosthesis assembly with ligament link
US8506597Oct 25, 2011Aug 13, 2013Biomet Sports Medicine, LlcMethod and apparatus for interosseous membrane reconstruction
US8551140Jul 13, 2011Oct 8, 2013Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US8562645May 2, 2011Oct 22, 2013Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US8562647Oct 29, 2010Oct 22, 2013Biomet Sports Medicine, LlcMethod and apparatus for securing soft tissue to bone
US8567609Apr 19, 2011Oct 29, 2013Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8574235May 19, 2011Nov 5, 2013Biomet Sports Medicine, LlcMethod for trochanteric reattachment
US8574238Oct 28, 2005Nov 5, 2013Depuy Mitek, LlcInstruments, kit and method for suture management
US8591391Apr 12, 2010Nov 26, 2013Biomet Biologics, LlcMethod and apparatus for separating a material
US8596470Feb 20, 2012Dec 3, 2013Hanuman, LlcBuoy fractionation system
US8597327Nov 3, 2010Dec 3, 2013Biomet Manufacturing, LlcMethod and apparatus for sternal closure
US8603346Sep 22, 2011Dec 10, 2013Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8608777Oct 21, 2011Dec 17, 2013Biomet Sports MedicineMethod and apparatus for coupling soft tissue to a bone
US8632569Dec 20, 2012Jan 21, 2014Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US8637066Sep 21, 2010Jan 28, 2014Depuy Mitek, LlcBiocompatible scaffold for ligament or tendon repair
US8641775 *Feb 1, 2011Feb 4, 2014Depuy Mitek, LlcViable tissue repair implants and methods of use
US8652171May 2, 2011Feb 18, 2014Biomet Sports Medicine, LlcMethod and apparatus for soft tissue fixation
US8652172Jul 6, 2011Feb 18, 2014Biomet Sports Medicine, LlcFlexible anchors for tissue fixation
US8672968Feb 8, 2010Mar 18, 2014Biomet Sports Medicine, LlcMethod for implanting soft tissue
US8672969Oct 7, 2011Mar 18, 2014Biomet Sports Medicine, LlcFracture fixation device
US8691259Nov 16, 2005Apr 8, 2014Depuy Mitek, LlcReinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US8721684Mar 5, 2012May 13, 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US8771316Mar 5, 2012Jul 8, 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US8771352May 17, 2011Jul 8, 2014Biomet Sports Medicine, LlcMethod and apparatus for tibial fixation of an ACL graft
US8777956Aug 16, 2012Jul 15, 2014Biomet Sports Medicine, LlcChondral defect repair
US8783470May 25, 2012Jul 22, 2014Biomet Biologics, LlcMethod and apparatus for producing autologous thrombin
US8801586 *Dec 20, 2012Aug 12, 2014Biomet Biologics, LlcSystem and process for separating a material
US8801783May 27, 2010Aug 12, 2014Biomet Sports Medicine, LlcProsthetic ligament system for knee joint
US8808309Feb 7, 2006Aug 19, 2014Ivy Sports Medicine, LlcSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US8808551Nov 15, 2010Aug 19, 2014Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US8840645Feb 17, 2012Sep 23, 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US8895045May 8, 2012Nov 25, 2014Depuy Mitek, LlcMethod of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US8900314Dec 19, 2012Dec 2, 2014Biomet Manufacturing, LlcMethod of implanting a prosthetic knee joint assembly
US8906110Sep 14, 2010Dec 9, 2014Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US8932331Mar 5, 2012Jan 13, 2015Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US8936621Nov 3, 2011Jan 20, 2015Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US8950586Jul 1, 2013Feb 10, 2015Hanuman LlcMethods and apparatus for isolating platelets from blood
US8968364May 17, 2011Mar 3, 2015Biomet Sports Medicine, LlcMethod and apparatus for fixation of an ACL graft
US8992862Nov 15, 2012Mar 31, 2015Biomet Biologics, LlcAll-in-one means of separating blood components
US8998949Aug 16, 2006Apr 7, 2015Biomet Sports Medicine, LlcSoft tissue conduit device
US9005287Nov 4, 2013Apr 14, 2015Biomet Sports Medicine, LlcMethod for bone reattachment
US9011800Jul 16, 2009Apr 21, 2015Biomet Biologics, LlcMethod and apparatus for separating biological materials
US9017381Apr 10, 2007Apr 28, 2015Biomet Sports Medicine, LlcAdjustable knotless loops
US9078644Mar 8, 2010Jul 14, 2015Biomet Sports Medicine, LlcFracture fixation device
US9113954Mar 23, 2012Aug 25, 2015DePuy Synthes Products, Inc.Coordinate instrument set
US9114334Dec 9, 2013Aug 25, 2015Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US9138664Dec 2, 2013Sep 22, 2015Biomet Biologics, LlcBuoy fractionation system
US9149267Nov 10, 2011Oct 6, 2015Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US9173651Oct 22, 2012Nov 3, 2015Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US9211362Jun 8, 2012Dec 15, 2015Depuy Mitek, LlcScaffold for connective tissue repair
US9216078May 8, 2013Dec 22, 2015Biomet Sports Medicine, LlcMethod and apparatus for tibial fixation of an ACL graft
US9239276Oct 28, 2013Jan 19, 2016Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US9259217Jan 3, 2012Feb 16, 2016Biomet Manufacturing, LlcSuture Button
US9265610Jul 12, 2010Feb 23, 2016Peter ForsellImplantable medical device for lubrication of a synovial joint and method for implanting the device
US9271713Nov 14, 2011Mar 1, 2016Biomet Sports Medicine, LlcMethod and apparatus for tensioning a suture
US9277999 *Feb 26, 2010Mar 8, 2016University of Pittsburgh—of the Commonwealth System of Higher EducationJoint bioscaffolds
US9314241Feb 1, 2013Apr 19, 2016Biomet Sports Medicine, LlcApparatus for coupling soft tissue to a bone
US9314340Jun 26, 2014Apr 19, 2016University of Pittsburgh—of the Commonwealth System of Higher EducationJoint bioscaffolds
US9357991Dec 19, 2012Jun 7, 2016Biomet Sports Medicine, LlcMethod and apparatus for stitching tendons
US9357992Feb 1, 2013Jun 7, 2016Biomet Sports Medicine, LlcMethod for coupling soft tissue to a bone
US9370350Mar 8, 2013Jun 21, 2016Biomet Sports Medicine, LlcApparatus for coupling soft tissue to a bone
US9381013Mar 8, 2013Jul 5, 2016Biomet Sports Medicine, LlcMethod for coupling soft tissue to a bone
US9402616Mar 2, 2012Aug 2, 2016Ivy Sports Medicine, LlcSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US9402621Sep 24, 2012Aug 2, 2016Biomet Sports Medicine, LLC.Method for tissue fixation
US9414833Feb 14, 2013Aug 16, 2016Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US9414925Aug 5, 2013Aug 16, 2016Biomet Manufacturing, LlcMethod of implanting a knee prosthesis assembly with a ligament link
US9433407Jan 6, 2016Sep 6, 2016Biomet Manufacturing, LlcMethod of implanting a bone fixation assembly
US9445827Aug 12, 2013Sep 20, 2016Biomet Sports Medicine, LlcMethod and apparatus for intraosseous membrane reconstruction
US9468433Nov 3, 2011Oct 18, 2016Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US9486211Mar 14, 2014Nov 8, 2016Biomet Sports Medicine, LlcMethod for implanting soft tissue
US9486558May 8, 2008Nov 8, 2016Locate Therapeutics LimitedPorous matrix
US9492158Jan 28, 2013Nov 15, 2016Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US9498204Jul 7, 2014Nov 22, 2016Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US9504460Oct 5, 2012Nov 29, 2016Biomet Sports Medicine, LLC.Soft tissue repair device and method
US20030023316 *Jun 14, 2002Jan 30, 2003Brown Laura JeanHybrid biologic-synthetic bioabsorable scaffolds
US20030033022 *Jul 15, 2002Feb 13, 2003Plouhar Pamela LynnCartilage repair and regeneration device and method
US20030036797 *Jul 15, 2002Feb 20, 2003Prasanna MalaviyaMeniscus regeneration device and method
US20030044444 *Jul 15, 2002Mar 6, 2003Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20030078617 *Jul 15, 2002Apr 24, 2003Schwartz Herbert E.Unitary surgical device and method
US20040054417 *Apr 9, 2001Mar 18, 2004Renzo SoffiatiDisposable articulated spacing device for surgical treatment of joints of the human body
US20040059431 *Sep 5, 2003Mar 25, 2004Plouhar Pamela L.Reinforced small intestinal submucosa
US20040143344 *Dec 29, 2003Jul 22, 2004Prasanna MalaviyaImplantable tissue repair device and method
US20040166169 *Jul 15, 2002Aug 26, 2004Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20040180822 *Aug 7, 2003Sep 16, 2004Grafton R. DonaldMethod of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US20040220574 *Jul 15, 2002Nov 4, 2004Pelo Mark JosephDevice from naturally occuring biologically derived materials
US20040230303 *May 16, 2003Nov 18, 2004Gomes Katherine A.Cartilage allograft plug
US20040267362 *Jun 30, 2003Dec 30, 2004Julia HwangScaffold for connective tissue repair
US20050027307 *Jul 15, 2002Feb 3, 2005Schwartz Herbert EugeneUnitary surgical device and method
US20050038520 *Aug 11, 2003Feb 17, 2005Francois BinetteMethod and apparatus for resurfacing an articular surface
US20050090139 *Mar 7, 2003Apr 28, 2005Rowland WhiteContact
US20050119756 *Jan 5, 2005Jun 2, 2005Tecres S.P.A.Disposable articulated spacing device for surgical treatment of joints of the human body
US20050125073 *Dec 8, 2003Jun 9, 2005Orban Janine M.Implant device for cartilage regeneration in load bearing articulation regions
US20050125077 *Dec 5, 2003Jun 9, 2005Harmon Alexander M.Viable tissue repair implants and methods of use
US20050222687 *Apr 2, 2004Oct 6, 2005Gordana Vunjak-NovakovicCartilage implant assembly and method for implantation
US20050249771 *Apr 20, 2005Nov 10, 2005Prasanna MalaviyaHybrid biologic-synthetic bioabsorbable scaffolds
US20050249772 *Apr 20, 2005Nov 10, 2005Prasanna MalaviyaHybrid biologic-synthetic bioabsorbable scaffolds
US20050251268 *Jun 14, 2005Nov 10, 2005Musculoskeletal Transplant FoundationCartilage allograft plug
US20060095053 *Oct 28, 2005May 4, 2006Zannis Anthony DMethod of delivering therapeutic implant
US20060095054 *Oct 28, 2005May 4, 2006Zannis Anthony DInstruments, kit and method for suture management
US20060128296 *Oct 29, 2004Jun 15, 2006Schwan Wade EIntestine processing device and associated method
US20060135638 *Dec 22, 2004Jun 22, 2006Pedrozo Hugo AMethod for organizing the assembly of collagen fibers and compositions formed therefrom
US20060178680 *Feb 7, 2006Aug 10, 2006Regen Biologics, Inc.System and method for all-inside suture fixation for implant attachment and soft tissue repair
US20060189993 *Apr 20, 2006Aug 24, 2006Arthrotek, Inc.Soft tissue conduit device
US20060190042 *Feb 3, 2006Aug 24, 2006Arthrotek, Inc.Tissue repair assembly
US20060210643 *Mar 16, 2005Sep 21, 2006Truncale Katherine A GCartilage repair mixture containing allograft chondrocytes
US20060211953 *Oct 28, 2005Sep 21, 2006Zannis Anthony DCoordinate instrument set
US20060263335 *Mar 29, 2004Nov 23, 2006Regentec Ltd.Porous matrix
US20060271201 *May 25, 2005Nov 30, 2006Biomet Manufacturing Corp.Porous ceramic structure containing biologics
US20060273050 *May 25, 2006Dec 7, 2006Higgins Joel CApparatus and method for separating and concentrating fluids containing multiple components
US20070034579 *Oct 19, 2006Feb 15, 2007Randel DorianMethods and apparatus for isolating platelets from blood
US20070129811 *Oct 10, 2006Jun 7, 2007Plouhar Pamela LReinforced small intestinal submucosa
US20070162055 *Feb 15, 2007Jul 12, 2007Bowman Steven MGraft fixation device combination
US20070276191 *May 26, 2006Nov 29, 2007Sean SeloverIlluminated surgical access system including a surgical access device and integrated light emitter
US20080071385 *Nov 29, 2007Mar 20, 2008Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US20080082128 *Sep 29, 2006Apr 3, 2008Arthrotek, Inc.Method and apparatus for forming a self-locking adjustable suture loop
US20080125863 *Nov 28, 2006May 29, 2008Mckay William FImplant designs and methods of improving cartilage repair
US20080133008 *Jan 31, 2008Jun 5, 2008Muscuoskeletal Transplant FoundationCartilage repair mixture containing allograft chondrocytes
US20080140094 *Dec 11, 2006Jun 12, 2008Schwartz Herbert EUnitary surgical device and method
US20080217264 *May 19, 2008Sep 11, 2008Biomet Manufacturing Corp.Apparatus And Method For Separating And Concentrating Fluids Containing Multiple Components
US20080217265 *May 19, 2008Sep 11, 2008Biomet Manufacturing Corp.Apparatus And Method for Separating And Concentrating Fluids Containing Multiple Components
US20080255676 *Jan 24, 2007Oct 16, 2008Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US20080269762 *Apr 25, 2007Oct 30, 2008Biomet Manufacturing Corp.Method and device for repair of cartilage defects
US20080274157 *Mar 26, 2008Nov 6, 2008Gordana Vunjak-NovakovicCartilage implant plug with fibrin glue and method for implantation
US20080283474 *Apr 11, 2008Nov 20, 2008Biomet Biologics, LlcBuoy suspension fractionation system
US20090101599 *Dec 29, 2008Apr 23, 2009Hanuman, L.L.C.Methods And Apparatus For Isolating Platelets From Blood
US20090149893 *Dec 4, 2008Jun 11, 2009Semler Eric JCancellous Bone Implant for Cartilage Repair
US20090221075 *Feb 27, 2009Sep 3, 2009Biomet Manufacturing Corp.System And Process For Separating A Material
US20090291112 *Feb 9, 2009Nov 26, 2009Truncale Katherine GAllograft osteochondral plug combined with cartilage particle mixture
US20090319045 *Mar 5, 2009Dec 24, 2009Truncale Katherine GCancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20100015202 *Jul 24, 2009Jan 21, 2010Semler Eric JCancellous construct with support ring for repair of osteochondral defects
US20100222882 *Feb 26, 2010Sep 2, 2010Badylak Stephen FJoint bioscaffolds
US20100256595 *Apr 3, 2009Oct 7, 2010Biomet Biologics, LlcAll-In-One Means Of Separating Blood Components
US20110009963 *Sep 21, 2010Jan 13, 2011Depuy Mitek, Inc.Biocompatible scaffold for ligament or tendon repair
US20110014705 *Jul 16, 2009Jan 20, 2011Biomet Biologics, LlcMethod and apparatus for separating biological materials
US20110056893 *Nov 15, 2010Mar 10, 2011Biomet Biologics, LLC.Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US20110091517 *Nov 22, 2010Apr 21, 2011Depuy Mitek, Inc.Biocompatible scaffolds with tissue fragments
US20110097381 *Dec 29, 2010Apr 28, 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US20110168193 *Mar 25, 2011Jul 14, 2011Biomet Biologics, LlcApparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US20110177134 *Feb 1, 2011Jul 21, 2011Depuy Mitek, Inc.Viable Tissue Repair Implants and Methods of Use
US20110185560 *Feb 18, 2011Aug 4, 2011Qioptiq Photonics Gmbh & Co. KgMethod for producing an objective
US20120114755 *Jun 22, 2010May 10, 2012Mayo Foundation For Medical Education And ResearchMethods and materials for tissue repair
US20130060334 *Feb 23, 2011Mar 7, 2013Orteq B.V.Meniscus repair assembly and method
US20150224147 *Jan 30, 2013Aug 13, 2015Nu Tech Medical, Inc.Placental Membrane Preparation and Methods of Making and Using Same
USRE42208Jun 26, 2008Mar 8, 2011Musculoskeletal Transplant FoundationGlue for cartilage repair
USRE43258Dec 13, 2010Mar 20, 2012Musculoskeletal Transplant FoundationGlue for cartilage repair
EP1652473A1Oct 28, 2005May 3, 2006DePuy Products, Inc.Implant system with sizing templates
EP1652484A1Oct 28, 2005May 3, 2006DePuy Products, Inc.Instruments, kit and method for suture managment
WO2011005185A1 *Jul 12, 2010Jan 13, 2011Milux Holding S.A.Implantable medical device for lubrication of a synovial joint and method for implanting the device
Classifications
U.S. Classification623/23.57, 623/23.63, 424/423
International ClassificationA61P19/00, C12N5/08, A61F2/28, A61F2/46, A61L27/00, A61L27/36, A61F2/30, A61F2/00, A61L27/18, A61L27/56, A61F2/44, A61F2/38, A61B17/04, A61L31/00, A61B17/064, A61B17/00, A61F2/08, A61B17/06, A61F2/02
Cooperative ClassificationA61F2002/30878, A61L31/005, A61F2002/30764, A61F2002/30281, A61F2002/30217, A61L27/3852, A61F2/3094, A61F2002/30429, A61F2240/001, A61F2230/0019, A61F2002/30294, A61F2002/2817, A61F2240/004, A61L27/3654, A61F2230/0013, A61F2002/30891, A61B2017/0475, A61F2/30749, A61B2017/0647, A61F2230/0082, A61L2430/06, A61F2002/30233, A61F2002/30153, A61F2002/30062, A61F2002/30892, A61F2002/30225, A61L27/3633, A61F2/3872, A61F2002/30914, A61F2002/30766, A61F2002/2839, A61F2002/3021, A61B2017/0646, A61F2230/0063, A61F2002/30224, A61B17/0642, A61F2002/30199, A61F2/30756, A61F2002/30611, A61F2/442, A61F2002/30957, A61F2002/30293, A61F2002/30032, A61F2/30965, A61B2017/00004, A61B2017/06057, A61L27/3604, A61F2250/003, A61F2002/30841, A61F2002/30971, A61F2210/0004, A61L27/18, A61F2002/30785, A61F2002/30131, A61B17/064, A61F2250/0063, A61F2002/30848, A61F2230/0091, A61B17/0401, A61F2002/30678, A61F2/08, A61F2230/0067, A61F2002/30751, A61F2/0811, A61F2220/0025, A61F2/0063, A61L27/3683, A61B2017/0641, A61F2/28, A61F2002/30975, A61L27/56, A61B17/06166, A61F2002/30677, A61F2002/30261, A61F2002/3096, A61F2230/0086, A61F2230/0069, A61F2250/0067, A61F2310/00365
European ClassificationA61L27/36B14, A61L27/36F2D, A61L27/38D2D, A61L27/18, A61L27/36B, A61F2/08F, A61L27/36H, A61F2/00H, A61L27/56, A61F2/30C, A61F2/28, A61B17/064, A61F2/30B10, A61F2/08, A61B17/064B, A61L31/00F, A61F2/38M
Legal Events
DateCodeEventDescription
Jan 19, 2010ASAssignment
Owner name: DEPUY PRODUCTS, INC., INDIANA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PLOUHAR, PAMELA L.;SCHWARTZ, HERBERT E.;MALAVIYA, PRASANNA;REEL/FRAME:023809/0475;SIGNING DATES FROM 20050802 TO 20090806